Shuttle Pharmaceuticals Files 8-K with Material Agreement
Ticker: SHPH · Form: 8-K · Filed: Dec 19, 2024 · CIK: 1757499
| Field | Detail |
|---|---|
| Company | Shuttle Pharmaceuticals Holdings, Inc. (SHPH) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.00001, $291,607 |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, filing, corporate-event
TL;DR
Shuttle Pharma signed a big deal on 12/16, filed 8-K on 12/19.
AI Summary
On December 16, 2024, Shuttle Pharmaceuticals Holdings, Inc. entered into a Material Definitive Agreement. The company also reported other events and filed financial statements and exhibits. The filing was made on December 19, 2024.
Why It Matters
This 8-K filing indicates a significant development for Shuttle Pharmaceuticals, likely involving a new contract or partnership that could impact its business operations and future prospects.
Risk Assessment
Risk Level: medium — Material Definitive Agreements can introduce new risks or opportunities, and the lack of specific details in this initial filing warrants a medium risk assessment.
Key Players & Entities
- Shuttle Pharmaceuticals Holdings, Inc. (company) — Registrant
- December 16, 2024 (date) — Date of earliest event reported
- December 19, 2024 (date) — Filing date
- Delaware (jurisdiction) — State of incorporation
- Gaithersburg, MD (location) — Principal executive offices
FAQ
What is the nature of the Material Definitive Agreement entered into by Shuttle Pharmaceuticals?
The filing states that Shuttle Pharmaceuticals Holdings, Inc. entered into a Material Definitive Agreement on December 16, 2024, but the specific details of this agreement are not provided in the provided text.
When was this 8-K report filed with the SEC?
This 8-K report was filed with the SEC on December 19, 2024.
What is the principal executive office address for Shuttle Pharmaceuticals Holdings, Inc.?
The principal executive offices are located at 401 Professional Drive, Suite 260, Gaithersburg, MD 20879.
What is the SIC code for Shuttle Pharmaceuticals Holdings, Inc.?
The Standard Industrial Classification (SIC) code for Shuttle Pharmaceuticals Holdings, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Shuttle Pharmaceuticals Holdings, Inc.?
The fiscal year end for Shuttle Pharmaceuticals Holdings, Inc. is December 31.
Filing Stats: 916 words · 4 min read · ~3 pages · Grade level 12.1 · Accepted 2024-12-19 09:00:20
Key Financial Figures
- $0.00001 — ange on which registered Common Stock $0.00001 per share SHPH The Nasdaq Stock Mar
- $291,607 — the Company will bear the total cost of $291,607 of the Research Program. The Company ha
Filing Documents
- form8-k.htm (8-K) — 44KB
- ex10-1.htm (EX-10.1) — 111KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-24-050700.txt ( ) — 365KB
- shph-20241216.xsd (EX-101.SCH) — 3KB
- shph-20241216_lab.xml (EX-101.LAB) — 33KB
- shph-20241216_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Dated: December 19, 2024 By: /s/ Anatoly Dritschilo Name: Anatoly Dritschilo Title: Chief Executive Officer